Edwyn
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $8,473 | $10,476 | $10,580 | $9,210 | $9,382 |
| Gross Profit | $1,975 | $2,500 | $2,137 | $2,061 | $2,290 |
| Operating Income | N/A | N/A | N/A | N/A | N/A |
| Net Income | $478 | $857 | $793 | $894 | $905 |
Over the five-year period, Eastman Chemical Co. experienced notable fluctuations in its revenue and gross profit margins. Revenue grew sharply from USD 8,473 million in 2020 to USD 10,476 million in 2021 – an increase of nearly 24% – which was accompanied by a rise in gross profit from USD 1,975 million to USD 2,500 million. However, by 2023, revenue declined to USD 9,210 million (a drop of about 13% from the previous peak in 2022), though it modestly recovered to USD 9,382 million in 2024. Gross profit followed a similar trend, peaking in 2021, dipping in 2022 and 2023, and rebounding somewhat in 2024. Operating income is consistently reported as zero across all five years, suggesting either unavailability or exclusion of this metric, which limits deeper insights into core operational performance. Net income, however, demonstrated robust performance over the period. Starting at USD 478 million in 2020, net income surged to USD 857 million in 2021—a significant jump that likely reflects improved efficiency or favorable market conditions. Although there was a slight dip to USD 793 million in 2022, net income recovered to USD 894 million in 2023 and edged higher to USD 905 million in 2024. This steady improvement in profitability, despite revenue volatility, underlines the firm’s ability to manage costs and maintain margins amid market fluctuations typical within the specialty chemicals industry. Overall, Eastman Chemical Co. appears to sustain its financial health with consistent net income growth, though further transparency on operating income would provide additional context on the sustainability of its performance.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.